Original Article

Thoracic Sarcoma: A New Glance at the Epidemiological Characteristics of Disease in Iran from 2009 to 2014

Abstract

Background: The heterogeneity, high rate of mortality and lack of comprehensive diagnostic methods have categorized primary sarcomas of the thorax as a malignancy with dismal outcomes and unknown etiology. Given the fundamental role of epidemiological analysis in establishing management strategies, we designed a study with focus on the epidemiological characteristics of primary thoracic sarcomas in Iran.  

Methods: This national population-based cancer study was conducted on patients with histologically confirmed sarcoma of the thorax referred to the Iranian National Cancer Registry between 2009 and 2014. The incidence was calculated as number of cases per 100,000 person-years and was age-adjusted by the direct method using the weight of the 1960 world standard population.  

Results: Over a 6-year period, 1477 cases with pathologically confirmed thoracic sarcomas were registered in Iran, of which 896 were male and 581 were female. Khuzestan Province had the highest incidence of thoracic sarcomas as compared to other provinces. Malignant mesothelioma was the most common histological subtype (20.85%). Moreover, the age-standardized incidence rate (ASR) of the disease was 1.94 per 100,000 which was more common in males than females with the highest incidence rate in men aged more than 65 years. 

Conclusion: Our study provided valuable epidemiologic data on characteristics of thoracic sarcomas. This data can be used for strategizing preventive measures.

1. Miller R, J Young, Novakovic B (1995). Childhood cancer. Cancer, 75: 395-405.
2. Jo VY, CD Fletcher (2014). WHO classifica-tion of soft tissue tumours: an update based on the 2013 4th ed. Pathology, 46(2): 95-104.
3. Siegel RL, KD Miller, et al (2016). Cancer statistics. Cancer J Clin, 66(1): 7-30.
4. Fletcher, C (2002). World Health Organiza-tion classification of Tumours. Pathology and genetics of Tumours of soft tissue and bone. Vol 4. Irac.`
5. Zahm SH, J Fraumeni (1997). The epidemi-ology of soft tissue sarcoma. Semin Oncol, 24: 504-14.
6. Gladish GW, Sabloff BM, Munden RF, et al (2002). Primary thoracic sarcomas. Radi-ographics, 22(3): 621-37.
7. Lawrence Jr W, Donegan WL, Natarajan N, et al (1987). Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons. Ann Surg, 205(4): 349-59.
8. Amano J, Nakayama J, Yoshimura Y, et al (2013). Clinical classification of cardiovas-cular tumors and tumor-like lesions, and its incidences. Gen Thorac Cardiovasc Surg, 61(8): 435-47.
9. Essary LR, SO Vargas, CD Fletcher (2002). Primary pleuropulmonary synovial sar-coma: reappraisal of a recently described anatomic subset. Cancer, 94(2): 459-69.
10. Etienne-Mastroianni B, Falchero L, Chala-breysse L, et al (2002). Primary sarcomas of the lung: a clinicopathologic study of 12 cases. Lung Cancer, 38(3): 283-9.
11. A Orlandi, A Ferlosio, M Roselli, et al (2010). Cardiac sarcomas: an update. J Thorac Oncol, 5(9): 1483-9.
12. GY Hung, CC Yen, JL Horng, et al (2015). Incidences of primary soft tissue sarcoma diagnosed on extremities and trunk wall: A population-based study in Taiwan. Medicine (Baltimore), 94(41):e1696.
13. Wibmer C, Leithner A, Zielonke N, et al (2010). Increasing incidence rates of soft tissue sarcomas? A population-based ep-idemiologic study and literature review. Ann Oncol, 21(5):1106-11.
14. P Bao, Y Zhou, W Lu, et al (2019). Inci-dence and mortality of sarcomas in Shanghai, China, during 2002-2014. Front Oncol, 9: 662.
15. Stiller CA, Trama A, Serraino D, et al (2013). Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J cancer, 49(3): 684-95.
16. JR Toro, LB Travis, HJ Wu, et al (2006). In-cidence patterns of soft tissue sarcomas, regardless of primary site, in the surveil-lance, epidemiology and end results pro-gram, 1978–2001: an analysis of 26,758 cases. Int J Cancer, 119(12): 2922-30.
17. Francis M, Dennis N, Charman j, et al (2013). Bone and soft tissue sarcomas UK incidence and survival: National Cancer Intelligence Network 1996 to 2010, pp 7-12.
Files
IssueVol 51 No 4 (2022) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijph.v51i4.9247
Keywords
Sarcoma Thorax Mesothelioma Incidence Iran
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Rahmani Seraji H, Akbari ME, Rezvani H, Bashash D, Mabani M, Akbari A, Raeisi A, Janbabee G, Salari S. Thoracic Sarcoma: A New Glance at the Epidemiological Characteristics of Disease in Iran from 2009 to 2014. Iran J Public Health. 2022;51(4):860-870.